|
US5945124A
(en)
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
FR2774288B1
(fr)
*
|
1998-01-30 |
2001-09-07 |
Ethypharm Sa |
Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
|
|
US7041313B1
(en)
|
1998-08-12 |
2006-05-09 |
Altana Pharma Ag |
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
|
|
JP2000128779A
(ja)
*
|
1998-10-20 |
2000-05-09 |
Mitsui Chemicals Inc |
薬物放出制御型製剤
|
|
FR2793688B1
(fr)
|
1999-05-21 |
2003-06-13 |
Ethypharm Lab Prod Ethiques |
Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
|
|
GB9923045D0
(en)
*
|
1999-09-29 |
1999-12-01 |
Novartis Ag |
New oral formulations
|
|
GB9923436D0
(en)
*
|
1999-10-04 |
1999-12-08 |
American Home Prod |
Pharmaceutical compositions
|
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
|
EP2295043A1
(en)
|
1999-10-29 |
2011-03-16 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
US7029701B2
(en)
*
|
2000-09-11 |
2006-04-18 |
Andrx Pharmaceuticals, Llc |
Composition for the treatment and prevention of ischemic events
|
|
US7157095B2
(en)
*
|
2000-10-13 |
2007-01-02 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release antifungal product, use and formulation thereof
|
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
|
AU2002227383B2
(en)
|
2000-10-30 |
2004-07-08 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
JP2002234842A
(ja)
*
|
2001-02-09 |
2002-08-23 |
Kyowa Yakuhin Kogyo Kk |
内服腸溶性製剤
|
|
US7316819B2
(en)
*
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
US20040253312A1
(en)
*
|
2001-09-28 |
2004-12-16 |
Sowden Harry S. |
Immediate release dosage form comprising shell having openings therein
|
|
US20050163846A1
(en)
*
|
2001-11-21 |
2005-07-28 |
Eisai Co., Ltd. |
Preparation composition containing acid-unstable physiologically active compound, and process for producing same
|
|
US8697094B2
(en)
|
2002-10-16 |
2014-04-15 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
|
EP1556024A4
(en)
*
|
2002-10-25 |
2007-01-17 |
Collegium Pharmaceutical Inc |
INTERMITTENT LIBERATION COMPOSITIONS OF MILNACIPRANE
|
|
EP1581196A4
(en)
*
|
2002-12-23 |
2007-08-22 |
Celltech Americas Inc |
SÄURELABILE MEDICINAL COMPOSITIONS
|
|
JP2004231520A
(ja)
*
|
2003-01-28 |
2004-08-19 |
Nichiko Pharmaceutical Co Ltd |
保存安定性及び溶出速度に優れた医薬組成物
|
|
US20040146558A1
(en)
*
|
2003-01-28 |
2004-07-29 |
Kyowa Pharmaceutical Co., Ltd. |
Oral enteric-coated preparation
|
|
CA2519208A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Takeda Pharmaceutical Company Limited |
Controlled release composition
|
|
JP4933033B2
(ja)
*
|
2003-03-17 |
2012-05-16 |
武田薬品工業株式会社 |
放出制御組成物
|
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
CA2533178C
(en)
|
2003-07-21 |
2014-03-11 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
|
JP2006528190A
(ja)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質製剤、その使用法及び作成方法
|
|
JP2006528185A
(ja)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質製剤、その使用法及び作成方法
|
|
WO2005016311A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
|
JP5686494B2
(ja)
*
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
|
ATE419841T1
(de)
*
|
2003-09-03 |
2009-01-15 |
Pharmaton Sa |
Kapseln enthaltend wirkstoffpellets mit unterschiedlichen freisetzungsprofilen
|
|
EP1663169A4
(en)
|
2003-09-15 |
2010-11-24 |
Middlebrook Pharmaceuticals In |
ANTIBIOTICS, ITS USE AND FORMULATION
|
|
KR20060092255A
(ko)
|
2003-09-26 |
2006-08-22 |
알자 코포레이션 |
고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
|
|
NZ546183A
(en)
*
|
2003-09-26 |
2011-04-29 |
Alza Corp |
Controlled release formulations exhibiting an ascending rate of release
|
|
DE602004032149D1
(de)
*
|
2003-09-26 |
2011-05-19 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
|
NZ546182A
(en)
*
|
2003-09-26 |
2009-08-28 |
Alza Corp |
Controlled release formulations of opioid and nonopioid analgesics such as hydrocodone and acetaminophen
|
|
TWI372066B
(en)
*
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
|
JP2005272347A
(ja)
*
|
2004-03-24 |
2005-10-06 |
Ohara Yakuhin Kogyo Kk |
固形製剤の製造方法
|
|
BRPI0509135A
(pt)
*
|
2004-03-26 |
2007-08-28 |
Eisai R&D Man Co Ltd |
composição farmacêutica de liberação controlada e método para produzir a mesma
|
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US8461187B2
(en)
*
|
2004-06-16 |
2013-06-11 |
Takeda Pharmaceuticals U.S.A., Inc. |
Multiple PPI dosage form
|
|
AU2011205024B2
(en)
*
|
2004-06-16 |
2012-09-06 |
Takeda Pharmaceutical Company Limited |
Multiple PPI dosage form
|
|
WO2006014427A1
(en)
|
2004-07-02 |
2006-02-09 |
Advancis Pharmaceutical Corporation |
Tablet for pulsed delivery
|
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
|
AR051654A1
(es)
*
|
2004-11-04 |
2007-01-31 |
Astrazeneca Ab |
Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
|
|
AR052225A1
(es)
*
|
2004-11-04 |
2007-03-07 |
Astrazeneca Ab |
Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
|
|
US7226454B2
(en)
*
|
2004-12-07 |
2007-06-05 |
Arizant Healthcare Inc. |
Warming device with varied permeability
|
|
WO2006111853A2
(en)
*
|
2005-04-18 |
2006-10-26 |
Aurobindo Pharma Limited |
Stable solid dosage forms of acid labile drug
|
|
US7803817B2
(en)
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
|
EP1754471A1
(de)
*
|
2005-08-18 |
2007-02-21 |
ORAMON-Arzneimittel GmbH & Co. KG |
Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
|
|
US20090148519A1
(en)
*
|
2005-09-29 |
2009-06-11 |
Yasuhiro Zaima |
Pulsed-release preparation having improved disintegration properties in vivo
|
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
|
CN101389316A
(zh)
|
2005-12-28 |
2009-03-18 |
武田药品工业株式会社 |
控制释放固体制剂
|
|
EP1967184A4
(en)
*
|
2005-12-28 |
2011-02-16 |
Takeda Pharmaceutical |
SOLID PREPARATION WITH CONTROLLED RELEASE
|
|
US9532945B2
(en)
*
|
2006-04-04 |
2017-01-03 |
Kg Acquisition Llc |
Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
|
|
US9504678B2
(en)
|
2006-04-04 |
2016-11-29 |
Kg Acquisition Llc |
Oral dosage forms including an antiplatelet agent and an acid inhibitor
|
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
|
US20100297226A1
(en)
*
|
2006-06-01 |
2010-11-25 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
|
EP2046334B1
(en)
|
2006-07-25 |
2014-05-21 |
Vecta Ltd. |
Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
|
|
WO2008062320A2
(en)
*
|
2006-10-06 |
2008-05-29 |
Eisai R&D Management Co., Ltd |
Extended release formulations of a proton pump inhibitor
|
|
ITMI20062290A1
(it)
*
|
2006-11-28 |
2008-05-29 |
Monteres S R L |
Compresse stabili allo stoccaggio a base di derivati del benzimidazolo rivestite con film gastro-resistente
|
|
EP1970056A1
(en)
*
|
2007-03-15 |
2008-09-17 |
Polichem S.A. |
Time-specific delayed/pulsatile release dosage forms
|
|
US20100104656A1
(en)
*
|
2007-03-20 |
2010-04-29 |
Paul Wan Sia Heng |
Meltable Binder for Melt Granulation and/or Pelletization
|
|
MX2010001071A
(es)
*
|
2007-07-27 |
2010-03-09 |
Depomed Inc |
Formas de dosificacion retentivas gastricas pulsatiles.
|
|
RU2010119041A
(ru)
*
|
2007-10-12 |
2011-11-20 |
Такеда Фармасьютикалз Норт Америка, Инк. (Us) |
Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
|
|
AU2009230676A1
(en)
*
|
2008-03-24 |
2009-10-01 |
Lupin Limited |
Delayed release compositions of duloxetine
|
|
KR20110079641A
(ko)
|
2008-09-09 |
2011-07-07 |
아스트라제네카 아베 |
제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
|
|
NZ597534A
(en)
*
|
2009-06-25 |
2013-09-27 |
Pozen Inc |
Method for treating a patient in need of aspirin therapy
|
|
MX2011013467A
(es)
|
2009-06-25 |
2012-02-13 |
Astrazeneca Ab |
Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
|
|
GB201003731D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Immediate/delayed drug delivery
|
|
GB201003734D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Delayed prolonged drug delivery
|
|
GB201003766D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Pulsatile drug release
|
|
WO2012051495A2
(en)
*
|
2010-10-15 |
2012-04-19 |
The Research Foundation Of State University Of New York |
Compositions and methods for enhancing the biological response to chemical agents and physical stimuli
|
|
US9539214B2
(en)
|
2011-12-28 |
2017-01-10 |
Pozen Inc. |
Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
|
JP6905972B2
(ja)
*
|
2016-02-23 |
2021-07-21 |
ニプロ株式会社 |
医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
|
|
WO2017145146A1
(en)
|
2016-02-25 |
2017-08-31 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
|
KR101884230B1
(ko)
*
|
2016-02-29 |
2018-08-01 |
주식회사 유영제약 |
에소메프라졸을 포함하는 제제
|
|
CN105796531A
(zh)
*
|
2016-04-13 |
2016-07-27 |
中国药科大学 |
一种右旋兰索拉唑择时脉冲控释微丸制剂及其制备方法
|
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
|
JP6915258B2
(ja)
*
|
2016-10-21 |
2021-08-04 |
ニプロ株式会社 |
医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
|
|
CN109125282B
(zh)
*
|
2018-09-05 |
2020-07-14 |
珠海润都制药股份有限公司 |
一种奥美拉唑肠溶胶囊及其制备方法
|